Risk factors of ipsilateral breast tumor recurrence in triple-negative or HER2-positive breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy.
Mizuho Tazo, Y. Kojima, A. Yoshida, Sayuka Nakayama, R. Tokui, T. Ogawa, T. Kuwayama, T. Nakayama, H. Yamauchi, K. Tsugawa, Seigo Nakamura, N. Hayashi, M. Ishitobi
{"title":"Risk factors of ipsilateral breast tumor recurrence in triple-negative or HER2-positive breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy.","authors":"Mizuho Tazo, Y. Kojima, A. Yoshida, Sayuka Nakayama, R. Tokui, T. Ogawa, T. Kuwayama, T. Nakayama, H. Yamauchi, K. Tsugawa, Seigo Nakamura, N. Hayashi, M. Ishitobi","doi":"10.1200/jco.2020.38.15_suppl.e12599","DOIUrl":null,"url":null,"abstract":"e12599Background: To date, patients undergo breast surgery after neoadjvant chemotherapy (NAC) even though they achieve clinical complete response (cCR). The safety of omitting breast surgery for t...","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":" ","pages":""},"PeriodicalIF":41.9000,"publicationDate":"2020-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/jco.2020.38.15_suppl.e12599","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
e12599Background: To date, patients undergo breast surgery after neoadjvant chemotherapy (NAC) even though they achieve clinical complete response (cCR). The safety of omitting breast surgery for t...
期刊介绍：
The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
